Cytax 300 Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Paclitaxel (300mg)
Overview Cytax 300 Injection
Oncaspar (Cytax 300 Injection equivalent) is a chemotherapy agent indicated for breast, pancreatic, and non-small cell lung cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined individually by your physician based on your condition and may vary. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdosage can lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue only under your physician's guidance. Common side effects include nausea, vomiting, and fatigue. Serious side effects, such as peripheral edema, alopecia, and weight increase, are possible. Concomitant medications may be prescribed to mitigate side effects. Report any unusual bruising, bleeding, sore throat, mouth sores, or fever immediately. This medication can lower blood cell counts (red and white blood cells), increasing infection risk. Regular blood tests to monitor blood cell levels and liver function are essential. Prior to treatment, disclose any heart, liver, or kidney conditions, and all medications, including antibiotics, to your doctor. Interactions with other medications are possible; comprehensive medication disclosure is vital. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is crucial for both partners throughout the treatment period.
Uses of Cytax 300 Injection
Cancers of the breast, lung (non-small cell type), and pancreas.
Major Benefits of Cytax 300 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cytax 300 Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Cytax 300 Injection:
Administering this medication will be handled by your healthcare provider. Please refrain from self-medication.
How Cytax 300 Injection works:
Cytax 300 Injection is a cancer treatment that disrupts the microtubules crucial for cancer cell division and proliferation. This action inhibits cancer cell growth, ultimately leading to their demise.
SAFETY ADVICE
AlcoholUNSAFE
Combining Cytax 300 Injection and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Cytax 300 Injection to pregnant individuals poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might consider its use if the potential benefits demonstrably outweigh the inherent dangers. Physician consultation is essential.
Breast feedingUNSAFE
Administration of Cytax 300 Injection is contraindicated while breastfeeding due to potential infant toxicity. Studies indicate a risk of harm to the nursing infant.
DrivingUNSAFE
Cytax 300 Injection may induce adverse reactions that could impair your driving ability. While driving between treatment cycles isn't prohibited, the injection's alcohol content suggests caution regarding driving.
KidneySAFE IF PRESCRIBED
Cytax 300 Injection poses no known safety risk for individuals with impaired renal function, and dose modification isn't typically necessary. Nevertheless, patients with pre-existing kidney conditions should consult their physician.
LiverCAUTION
Cytax 300 Injection requires careful administration in individuals with hepatic impairment. Dosage modification for Cytax 300 Injection might be necessary. Physician consultation is advised. Cytax 300 Injection is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Cytax 300 Injection :
NA
Facts to Know About Cytax 300 Injection
| Label | Value |
|---|---|
| Chemical Category | Taxane Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Taxanes: Antimicrotubule Agents |
3,018 People bought this recently
